王丹丹, 时文静, 李冰晨, 刘娟娟, 李妍, 荆雪宁. 抗白念珠菌生物膜的植物来源天然产物研究进展J. 药学学报, 2025, 60(9): 2649-2657. DOI: 10.16438/j.0513-4870.2025-0400
引用本文: 王丹丹, 时文静, 李冰晨, 刘娟娟, 李妍, 荆雪宁. 抗白念珠菌生物膜的植物来源天然产物研究进展J. 药学学报, 2025, 60(9): 2649-2657. DOI: 10.16438/j.0513-4870.2025-0400
WANG Dan-dan, SHI Wen-jing, LI Bing-chen, LIU Juan-juan, LI Yan, JING Xue-ning. Progresses of plant-derived natural products against Candida albicans biofilmJ. Acta Pharmaceutica Sinica, 2025, 60(9): 2649-2657. DOI: 10.16438/j.0513-4870.2025-0400
Citation: WANG Dan-dan, SHI Wen-jing, LI Bing-chen, LIU Juan-juan, LI Yan, JING Xue-ning. Progresses of plant-derived natural products against Candida albicans biofilmJ. Acta Pharmaceutica Sinica, 2025, 60(9): 2649-2657. DOI: 10.16438/j.0513-4870.2025-0400

抗白念珠菌生物膜的植物来源天然产物研究进展

Progresses of plant-derived natural products against Candida albicans biofilm

  • 摘要: 白念珠菌是临床真菌感染中最为常见的条件致病真菌, 生物膜的形成是白念珠菌侵袭致病和播散传染的重要因素。形成生物膜的白念珠菌对临床抗真菌药物的敏感性降低, 造成抗真菌治疗病程长、易复发和耐药性的产生, 因此低毒高效的具有生物膜抑制活性的抗真菌药物的研发十分重要。植物来源的天然产物因其多样化的化学结构和生物活性, 一直是药物研发的重要资源。本文总结了近5年报道的具有抗白念珠菌生物膜活性的植物来源的天然产物, 主要包括生物碱、多酚、萜类、醌类、有机酸和精油等, 为新型抗白念珠菌药物的开发提供参考。

     

    Abstract: Candida albicans (C. albicans) is the most prevalent conditionally pathogenic fungus implicated in clinical fungal infections. The formation of biofilms is a critical contributor to the pathogenicity of C. albicans, facilitating its invasion and the subsequent spread of infection. Biofilm-associated C. albicans exhibits reduced susceptibility to commonly used antifungal agents, leading to prolonged treatment durations, high rates of recurrence, and the emergence of drug resistance. Consequently, the development of antifungals that are both low in toxicity and effective in inhibiting biofilm formation is of paramount importance. Plant-derived natural products have emerged as a vital resource for drug discovery, owing to their diverse chemical structures and myriad biological activities. In this review, we provide a comprehensive summary of plant-derived natural products with demonstrated anti-biofilm activity against C. albicans, as reported over the past five years. This includes an examination of various classes of compounds such as alkaloids, polyphenols, terpenes, quinones, organic acids, and essential oils, thereby offering insights that may advance the development of novel anti-fungal therapeutics targeting C. albicans.

     

/

返回文章
返回